Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research    » Alternative Medicine    » Beta Cells    » Cause    » Cells    » Children    » Complications    » Control    » Cure    » Diagnosis    » Drugs    » Elderly    » Genes    » Immune Cells    » Inhaled Insulin    » Insulin    » Islet Cells    » Neuropathy    » Obesity    » Oral Insulin    » Other Diseases    » Pets    » Pre-Diabetes    » Prevention    » Research    » Retinopathy    » Risk Factors    » Stem Cells    » Technology    » Testing    » Transplants    » Treatments    » Trials    » Type 1    » Type 2 Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Research » Control

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Once-Weekly Exenatide Provides Glycemic Control and Weight Loss Posted: Wednesday, June 17, 2009

Once-weekly exenatide (EQW) produces superior improvements in glucose control and body weight compared with maximum daily doses of sitagliptin and pioglitazone on background metformin, according to study results presented at the ADA 69th Scientific Sessions.

Diabetic Retinopathy on the Rise Posted: Wednesday, June 17, 2009

After two decades on the rise, retinopathy now affects more than a third of all diabetes patients, according to the latest nationally representative estimate.

Inhaled Insulin AFRESA(R) Controls Post-Meal Sugar Levels with Less Weight Gain and Hypoglycemia Posted: Wednesday, June 17, 2009

The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA® (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of hypoglycemia for adult patients with diabetes.

Exenatide Not Associated with Increased Rate of Acute Pancreatitis Compared to other Antidiabetic Drugs Posted: Wednesday, June 17, 2009

Retrospective Cohort Study included more than 25,000 BYETTA patients accrued over three years.

Three New Weight-Loss Drugs Show Benefits for Diabetics Posted: Wednesday, June 17, 2009

Three investigational diet drugs hold promise for preventing and treating diabetes. The findings show that the drugs can help "halt the progression towards Type 2 diabetes.

Diabetes Associated with Hearing Loss Posted: Wednesday, June 17, 2009

Diabetic patients with poor glycemic control or vascular or neuropathic complications may also suffer from hearing loss. All patients with hemoglobin A1c levels greater than 7% had hearing impairment.

Liraglutide Reverses Prediabetes 90% Posted: Wednesday, June 17, 2009

Researchers at the ADA reported that Liraglutide reverses prediabetes indices in most obese patients with existing prediabetes.

GLP-1 Liraglutide Versus Sulfonylureas Posted: Wednesday, June 17, 2009

Novo Nordisk experimental diabetes drug liraglutide was significantly better at helping patients control blood sugar than an older common medicine after two years of treatment, according to data from a clinical trial.

New Fluorescent Technology for Glucose Sensors are Accurate Posted: Wednesday, June 17, 2009

A novel continuous glucose monitor that uses fluorescence to provide a read-out of blood sugar appears to be accurate, especially in the hypoglycemic range, researchers said at ADA.

New Screening Methods Work for Diabetic Retinopathy Posted: Wednesday, June 17, 2009

For diabetic retinopathy screening, telemedicine and photographing fewer fields allow for faster detection for more patients, researchers said.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.